Elevated expressions of survivin and VEGF protein are strong independent predictors of survival in advanced nasopharyngeal carcinoma.
about
Emerging concepts in biomarker discovery; the US-Japan Workshop on Immunological Molecular Markers in OncologyEffect of the vascular endothelial growth factor expression level on angiopoietin-2-mediated nasopharyngeal carcinoma growth.Molecular alterations in key-regulator genes among patients with T4 breast carcinoma.LATS2 is de-methylated and overexpressed in nasopharyngeal carcinoma and predicts poor prognosis.Functional polymorphism -31C/G in the promoter of BIRC5 gene and risk of nasopharyngeal carcinoma among chineseEpstein-Barr virus encoded latent membrane protein 1 regulates mTOR signaling pathway genes which predict poor prognosis of nasopharyngeal carcinomaAn Update on Translating Stem Cell Therapy for Stroke from Bench to Bedside.A global view of the oncogenic landscape in nasopharyngeal carcinoma: an integrated analysis at the genetic and expression levels.Radioactive ¹²⁵I seed inhibits the cell growth, migration, and invasion of nasopharyngeal carcinoma by triggering DNA damage and inactivating VEGF-A/ERK signaling.Avidity of CD1d-ligand-receptor ternary complex contributes to T-helper 1 (Th1) polarization and anticancer efficacy.Correlation between Liver Metastases and the Level of PRL-3 mRNA Expression in Patients with Primary Colorectal Cancer.Genetic Variants of VEGF (rs201963 and rs3025039) and KDR (rs7667298, rs2305948, and rs1870377) Are Associated with Glioma Risk in a Han Chinese Population: a Case-Control Study.The twisted survivin connection to angiogenesisEfficacy of BIBF 1120 or BIBF 1120 plus chemotherapy on nasopharyngeal carcinoma in vitro and in vivoInflammation and cancer: how friendly is the relationship for cancer patients?Impact of tumor cell VEGF expression on the in vivo efficacy of vandetanib (ZACTIMA; ZD6474).Targeting tumor hypoxia in nasopharyngeal carcinoma.Aurora kinase inhibitors: progress towards the clinicPrognostic value of vascular endothelial growth factor in patients with head and neck cancer: A meta-analysis.Targeting adaptive glioblastoma: an overview of proliferation and invasion.Transcriptome meta-analysis reveals dysregulated pathways in nasopharyngeal carcinoma.Using computational strategies to predict potential drugs for nasopharyngeal carcinoma.Inflammation and cancer.Association between VEGF-460T/C gene polymorphism and clinical outcomes of nasopharyngeal carcinoma treated with intensity-modulated radiation therapy.Nasopharyngeal carcinoma signaling pathway: an update on molecular biomarkers.MicroRNA deregulation and pathway alterations in nasopharyngeal carcinoma.Prognostic utility of apoptosis index, Ki-67 and survivin expression in dogs with nasal carcinoma treated with orthovoltage radiation therapy.Prospective validation of the prognostic value of elevated serum vascular endothelial growth factor in patients with nasopharyngeal carcinoma: more distant metastases and shorter overall survival after treatment.Increased expression of hepatoma-derived growth factor correlates with poor prognosis in human nasopharyngeal carcinoma.Fascin1 expression predicts poor prognosis in patients with nasopharyngeal carcinoma and correlates with tumor invasion.Molecular classification and molecular targeted therapy of cancer.Prognostic significance of clinical parameters and Epstein-Barr virus infection in non-endemic undifferentiated carcinoma of nasopharyngeal type: a Serbian report.Gene expression profile changes and possible molecular subtypes in differentiated-type nonkeratinizing nasopharyngeal carcinoma.Prognostic significance of expression of cyclooxygenase-2, vascular endothelial growth factor, and epidermal growth factor receptor in nasopharyngeal carcinoma.Prognostic Value of Molecular Markers and Implication for Molecular Targeted Therapies in Nasopharyngeal Carcinoma: An Update in an Era of New Targeted Molecules Development.Distal and proximal interleukin (IL)-10 promoter polymorphisms associated with risk of cutaneous melanoma development: a case--control study.Decreased expression of updated NESG1 in nasopharyngeal carcinoma: its potential role and preliminarily functional mechanism.Junctional adhesion molecule-A, an epithelial-mesenchymal transition inducer, correlates with metastasis and poor prognosis in human nasopharyngeal cancer.Addition of bevacizumab to systemic therapy for locally advanced and metastatic nasopharyngeal carcinoma.A Meta-Analysis of Vascular Endothelial Growth Factor for Nasopharyngeal Cancer Prognosis
P2860
Q30438965-E292A25D-521E-474F-900B-C406F4EDA4BBQ33588642-B1E620E1-C899-42E0-8368-6F6BFC1A9839Q33671525-82E3CD6E-1F37-4422-AA88-86CD9C870AB5Q33713184-668CA070-22C4-47C6-91F5-FD5A35258979Q33815287-2C3BA576-9E1E-4D5A-BA3C-B917C9EA99C5Q33818584-564B230B-95D8-4194-9954-FF2253DF43C3Q34107076-01233F69-B3BF-45AA-B061-61A63382927DQ34345591-F3364CF9-5CBD-4302-ACA5-E01861BEDA75Q34989673-9BC3072E-5C79-43B4-BF97-BEFAA8165110Q35409604-4CC4E0C3-9CED-4905-809E-AB1EBB6906F5Q35555652-036A8DF2-7FF4-4D23-8B2F-A0E34EC2D2F3Q35669479-08C7D6DD-40B1-46C3-92A2-1475DFEDBD6FQ36301932-101F7B30-39F3-4764-8954-7D38C4AAD53DQ36710062-B095BE88-CCE4-4E3E-87BE-958683709B09Q37316105-BA859D49-A1E4-437D-B60E-C088DECE7DAAQ37451272-2B0343EF-8132-486D-8AAF-07384EBC1EE1Q37959387-53F49A2E-82DE-4CD0-B82E-97399493600EQ37986455-77FC5E1D-4BD5-4058-BF88-5EF6FB948569Q38044324-3C107AC8-655A-4085-9B2D-3EC8FD9E9887Q38235930-F77EB155-BE8B-49B1-882E-1997E2126F1DQ38905388-BF46E44E-570F-46A6-BF2A-56C34F11E0BEQ39095740-DE966555-02D6-4BDF-B369-B3787C7D8C58Q41853728-3927E5D3-F0F5-4BEE-8C20-BDFBA4DA1710Q41991817-5304B5FF-9EA7-4AF1-92CD-1C517118152EQ42096715-721A5952-84F0-48C8-BA8F-4E8F8A424BD6Q42723195-99E955E2-6C23-4A4E-AD52-3F53B4F07017Q43074794-7C80A92D-C7F8-4049-BE41-493B575437FEQ44762095-70E6E602-7A48-4C89-AB28-ED2E82EEF1C8Q45024872-73BEAE4D-152C-4CC7-B93F-8185EBBB37A8Q45191513-AC49741E-2F30-47F8-9C66-D225ED274999Q45342194-E9CA4B11-AFBE-4E55-80D3-53093E38102FQ45376194-1A91062D-7333-4909-A573-3395D2C2DC09Q45412653-F5FFB0B0-BB37-4351-99E9-8359E6DE1E25Q45751366-EFACF427-35BA-476D-AB43-2CAC26269218Q47155578-8CE54425-C710-4F76-8979-F048FDC875A7Q47754476-D0DA0B71-84FC-43A9-B5C5-86B871D42141Q53305882-E27FCF24-2D88-4952-9A71-B471DDF84981Q54308436-7C089C48-AA58-40A2-90E4-070974EC1DBBQ55025647-2EF12AAD-A7B1-442B-94B4-5615F01A7CBEQ59133589-1D84782F-E765-4782-99E6-8BC29E7135AB
P2860
Elevated expressions of survivin and VEGF protein are strong independent predictors of survival in advanced nasopharyngeal carcinoma.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Elevated expressions of surviv ...... nced nasopharyngeal carcinoma.
@ast
Elevated expressions of surviv ...... nced nasopharyngeal carcinoma.
@en
type
label
Elevated expressions of surviv ...... nced nasopharyngeal carcinoma.
@ast
Elevated expressions of surviv ...... nced nasopharyngeal carcinoma.
@en
prefLabel
Elevated expressions of surviv ...... nced nasopharyngeal carcinoma.
@ast
Elevated expressions of surviv ...... nced nasopharyngeal carcinoma.
@en
P2093
P2860
P356
P1476
Elevated expressions of surviv ...... nced nasopharyngeal carcinoma.
@en
P2093
Chun-Fang Hu
Jian-Yong Shao
Jing-Hui Hou
Ma-Yan Huang
Qiong Shao
Yi-Xin Zeng
Yu-Hong Li
P2860
P2888
P356
10.1186/1479-5876-6-1
P577
2008-01-03T00:00:00Z
P5875
P6179
1045125614